MyEClinic
MyEClinic
Health Dictionary Find a Doctor

Membranoproliferative glomerulonephritis future or investigational therapies


Todays treatment of Membranoproliferative Glomerulonephritis is going to focus on monoclonal antibodies such as Rituximab, which is one of the most effective treatment.[1]

References

  1. ↑ Michael Rudnicki. “Rituximab for Treatment of Membranoproliferative Glomerulonephritis and C3 Glomerulopathies”. BioMed Research International.

Template:WH Template:WS

Looking for the patient version?

Back to the patient-friendly article

Imprint

Privacy Policy

Terms and Conditions

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH